---
title: "Machine-learning prediction of pacing-induced cardiomyopathy in AV block with preserved or mildly"
id: "medrxiv-11-machine-learning-based-prediction-of-pacing-induced-cardiomyopathy-in-patients"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-11-machine-learning-based-prediction-of-pacing-induced-cardiomyopathy-in-patients"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.09.26365179v1?rss=1"
published_at: "2026-10-13T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Machine-learning prediction of pacing-induced cardiomyopathy in AV block with preserved or mildly
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-11-machine-learning-based-prediction-of-pacing-induced-cardiomyopathy-in-patients
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.09.26365179v1?rss=1)
- **Published At:** 2026-10-13T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study developed and internally validated machine-learning (ML) models to predict **pacing-induced cardiomyopathy** (PICM) in patients with atrioventricular block (**AVB**) and baseline mildly reduced or preserved **LVEF**. - This analysis used data from the multicenter RISK-PICM registry spanning January 2002 to January 2026; the cohort comprised 125 pacemaker recipients. - PICM was defined by the authors as a ≥10% decline in LVEF to a value below 50%. - Over a median follow-up of 4.8 years, PICM occurred in 41 patients (32.8%). - Four algorithms were trained: logistic regression, support vector machine, random forest, and **XGBoost**; models used stratified 4-fold cross-validation and hyperparameter optimization per the report. - **XGBoost** produced the best discrimination (AUROC 0.831) with sensitivity 0.805 and specificity 0.845 as reported by the investigators. - Univariable Cox analysis linked male sex, pre-implant minimum QTc interval, and post-implant maximum QRS duration to PICM; feature-importance ranking placed baseline **LVEF** and post-implant maximum QRS duration highest. - Model-derived risk groups separated on Kaplan-Meier analysis (P < 0.001), according to the study team. - The paper reports Institutional Review Board approval and trial registration; competing interests noted that one author is CEO/founder of MitoKey, which supported analysis. - The authors conclude ML models—particularly **XGBoost**—may aid individualized pacing strategy selection; the source did not report external validation, implementation pathways, or detailed feature preprocessing steps.
## Clinical Analysis & Structured Key Points
Machine Learning-based Prediction of Pacing-Induced Cardiomyopathy in Patients with Atrioventricular Block Underlying Heart Failure with Mildly Reduced or Preserved Ejection Fraction | medRxiv Skip to main content Machine Learning-based Prediction of Pacing-Induced Cardiomyopathy in Patients with Atrioventricular Block Underlying Heart Failure with Mildly Reduced or Preserved Ejection Fraction Jang-Won Lee , View ORCID Profile Ungjeong Do , View ORCID Profile Hyue Mee Kim , Min Jea Choi , View ORCID Profile Seung Yong Shin , Seung Park , Ki-Woon Kang doi: https://doi.org/10.64898/2026.10.09.26365179 Jang-Won Lee 1 Chung-Ang University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ungjeong Do 2 Chung Ang University Hospital; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Ungjeong Do Hyue Mee Kim 2 Chung Ang University Hospital; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Hyue Mee Kim Min Jea Choi 3 MitoKey Co.,Ltd.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Seung Yong Shin 4 Cardiovascular & Arrhythmia Center, Chung-Ang University Hospital, Chung-Ang University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Seung Yong Shin Seung Park 5 The Catholic University of Korea Seoul St Mary's Hospital; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ki-Woon Kang 6 Chung-Ang University Hospital, Chung-Ang University College of Medicine Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: kwkang0115{at}gmail.com Abstract Info/History Metrics Data/Code Preview PDF Abstract Background: Pacing-induced cardiomyopathy (PICM) is a major complication of chronic right ventricular pacing and develops in up to 25% of patients. Reliable prediction of PICM may facilitate individualized pacing strategy selection; however, currently available approaches demonstrate limited discriminative performance. This study aimed to develop and validate machine learning (ML) models for predicting PICM in patients with atrioventricular block (AVB) underlying heart failure with mildly reduced or preserved ejection fraction. Methods: In this multicenter prospective study derived from the RISK-PICM registry (January 2002 to January 2026), 125 patients with AVB who underwent pacemaker implantation were analyzed. PICM was defined as a ?10% reduction in left ventricular ejection fraction (LVEF) resulting in an LVEF <50%. Four ML algorithms, including logistic regression, support vector machine, random forest, and XGBoost, were trained using stratified 4-fold cross-validation with hyperparameter optimization and model discrimination was evaluated. Results: PICM developed in 41 patients (32.8%) during a median follow-up of 4.8 years. Male sex, pre-implant minimum QTc interval, and post-implant maximum QRS duration were significantly associated with PICM in univariable Cox regression. XGBoost achieved the highest discriminative performance (AUROC 0.831; sensitivity 0.805; specificity 0.845). Feature importance analysis identified baseline LVEF and post-implant maximum QRS duration as the most influential features. Model-derived risk stratification significantly differentiated high-risk and low-risk groups on Kaplan-Meier analysis (P < 0.001). Conclusions: ML-based models, particularly XGBoost, demonstrated clinically meaningful performance for PICM and may support individualized pacing strategy selection in patients with AVB and underlying heart failure with mildly reduced or preserved ejection fraction. Competing Interest Statement Ki-Woon Kang is the CEO and Founder of MitoKey. MitoKey provided support for research analysis for this study. The other authors declare no competing interests." Clinical Trial NCT03475498 Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was reviewed and approved by the Institutional Review Board of Chung-Ang University Hospital (Approval No. 2018-006-474). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The data that support the findings are available from the corresponding author upon reasonable request. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted October 13, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Machine Learning-based Prediction of Pacing-Induced Cardiomyopathy in Patients with Atrioventricular Block Underlying Heart Failure with Mildly Reduced or Preserved Ejection Fraction Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Machine Learning-based Prediction of Pacing-Induced Cardiomyopathy in Patients with Atrioventricular Block Underlying Heart Failure with Mildly Reduced or Preserved Ejection Fraction Jang-Won Lee , Ungjeong Do , Hyue Mee Kim , Min Jea Choi , Seung Yong Shin , Seung Park , Ki-Woon Kang medRxiv 2026.10.09.26365179; doi: https://doi.org/10.64898/2026.10.09.26365179 Share This Article: Copy Citation Tools Machine Learning-based Prediction of Pacing-Induced Cardiomyopathy in Patients with Atrioventricular Block Underlying Heart Failure with Mildly Reduced or Preserved Ejection Fraction Jang-Won Lee , Ungjeong Do , Hyue Mee Kim , Min Jea Choi , Seung Yong Shin , Seung Park , Ki-Woon Kang medRxiv 2026.10.09.26365179; doi: https://doi.org/10.64898/2026.10.09.26365179 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (627) Allergy and Immunology (914) Anesthesia (343) Cardiovascular Medicine (4915) Dentistry and Oral Medicine (487) Dermatology (421) Emergency Medicine (666) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1652) Epidemiology (16109) Forensic Medicine (35) Gastroenterology (1222) Genetic and Genomic Medicine (7158) Geriatric Medicine (740) Health Economics (1079) Health Informatics (5173) Health Policy (1451) Health Systems and Quality Improvement (1803) Hematology (594) HIV/AIDS (1361) Infectious Diseases (except HIV/AIDS) (16391) Intensive Care and Critical Care Medicine (1187) Medical Education (683) Medical Ethics (156) Nephrology (732) Neurology (7427) Nursing (372) Nutrition (1108) Obstetrics and Gynecology (1270) Occupational and Environmental Health (1016) Oncology (3679) Ophthalmology (1076) Orthopedics (400) Otolaryngology (460) Pain Medicine (487) Palliative Medicine (142) Pathology (714) Pediatrics (1831) Pharmacology and Therapeutics (742) Primary Care Research (780) Psychiatry and Clinical Psychology (6020) Public and Global Health (9873) Radiology and Imaging (2475) Rehabilitation Medicine and Physical Therapy (1490) Respiratory Medicine (1257) Rheumatology (653) Sexual and Reproductive Health (791) Sports Medicine (590) Surgery (790) Toxicology (109) Transplantation (313) Urology (299)
## Related Clinical Research

- [Psychosocial profile in adults with congenital heart disease by documented anxiety disorder history](https://medichelpline.com/clinical-feed/plos-one-21-psychosocial-profile-of-adults-with-congenital-heart-disease-according-to.md)
- [Controlling Hypertension Could Avert Over 500,000 Deaths Annually, Analysis Finds](https://medichelpline.com/clinical-feed/medical-news-today-1-over-500-000-deaths-a-year-could-be-prevented-by-managing-blood-pressure.md)
- [Cardiovascular Risk Screening Before US Antarctic Deployment: Comparing PREVENT, PCE, and FRS](https://medichelpline.com/clinical-feed/medrxiv-12-pre-deployment-cardiovascular-risk-assessment-and-outcomes-among-united-states.md)
- [Cardiovascular risk prediction models in women: protocol for an updated systematic review](https://medichelpline.com/clinical-feed/plos-one-7-cardiovascular-risk-prediction-models-for-women-a-systematic-review-protocol.md)
- [C-QIP feasibility trial: Multicomponent quality improvement for chronic cardiovascular care in Ind](https://medichelpline.com/clinical-feed/plos-medicine-1-assessing-a-multicomponent-quality-improvement-strategy-for-chronic-care-of.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.